439 related articles for article (PubMed ID: 17156670)
21. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
[TBL] [Abstract][Full Text] [Related]
22. The clinical significance of antinuclear antibodies in connective tissue disease.
Pahor A; Krajnc I; Gorenjak M; Holc I
Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
Desplat-Jego S; Bardin N; Larida B; Sanmarco M
Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
[TBL] [Abstract][Full Text] [Related]
24. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases.
Lazzerini PE; Acampa M; Guideri F; Capecchi PL; Campanella V; Morozzi G; Galeazzi M; Marcolongo R; Laghi-Pasini F
Arthritis Rheum; 2004 Apr; 50(4):1248-52. PubMed ID: 15077308
[TBL] [Abstract][Full Text] [Related]
25. Comparison of three multiplex immunoassays for detection of antibodies to extractable nuclear antibodies using clinically defined sera.
Copple SS; Martins TB; Masterson C; Joly E; Hill HR
Ann N Y Acad Sci; 2007 Aug; 1109():464-72. PubMed ID: 17785335
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of an immunoblotting technique for the detection of anti-SSA and anti-SSB antibodies].
Yalaoui S; Gorgi Y; Ayed K
Pathol Biol (Paris); 2001 Apr; 49(3):265-9. PubMed ID: 11367563
[TBL] [Abstract][Full Text] [Related]
27. Detection of anti-Ro(SSA) antibodies in autoimmune diseases: comparison of five methods.
Manoussakis MN; Kistis KG; Liu X; Aidinis V; Guialis A; Moutsopoulos HM
Br J Rheumatol; 1993 Jun; 32(6):449-55. PubMed ID: 8508279
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
[TBL] [Abstract][Full Text] [Related]
29. Anti-Ro/SSA and La/SSB antibodies.
Franceschini F; Cavazzana I
Autoimmunity; 2005 Feb; 38(1):55-63. PubMed ID: 15804706
[TBL] [Abstract][Full Text] [Related]
30. Correlation between ANA determinations on tissue substrate, WiL-2 cell substrate, and precipitin antibody by double diffusion.
Deng JS; Bair LW; Medsger TA; Sontheimer RA
Diagn Clin Immunol; 1987; 5(3):151-7. PubMed ID: 3121208
[TBL] [Abstract][Full Text] [Related]
31. Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus.
Gordon P; Khamashta MA; Rosenthal E; Simpson JM; Sharland G; Brucato A; Franceschini F; De Bosschere K; Meheus L; Meroni PL; Hughes GR; Buyon J
J Rheumatol; 2004 Dec; 31(12):2480-7. PubMed ID: 15570655
[TBL] [Abstract][Full Text] [Related]
32. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
33. Specific testing for "isolated" anti-52 kDa SSA/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value.
Langguth DM; Morris S; Clifford L; Wilson RJ; Neil J; Hogan PG; Wong RC
J Clin Pathol; 2007 Jun; 60(6):670-3. PubMed ID: 17557869
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
35. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group.
Costedoat-Chalumeau N; Amoura Z; Lupoglazoff JM; Huong DL; Denjoy I; Vauthier D; Sebbouh D; Fain O; Georgin-Lavialle S; Ghillani P; Musset L; Wechsler B; Duhaut P; Piette JC
Arthritis Rheum; 2004 Oct; 50(10):3187-94. PubMed ID: 15476223
[TBL] [Abstract][Full Text] [Related]
36. Anti-SSA/Ro antibody determination by enzyme-linked immunosorbent assay as a supplement to standard immunofluorescence in antinuclear antibody screening.
Blomberg S; Ronnblom L; Wallgren AC; Nilsson B; Karlsson-Parra A
Scand J Immunol; 2000 Jun; 51(6):612-7. PubMed ID: 10849373
[TBL] [Abstract][Full Text] [Related]
37. [Comparison of indirect immunofluorescence assay and ELISA for detecting antinuclear antibodies and anti-double-stranded DNA antibodies].
Qin X; Tao X; Chen ZJ; Jiang JQ; Xu MH; Li RL; Li TJ; Lin FQ; Li S
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):472-5. PubMed ID: 19304528
[TBL] [Abstract][Full Text] [Related]
38. Outcome of infants from mothers with anti-SSA/Ro antibodies.
Motta M; Rodriguez-Perez C; Tincani A; Lojacono A; Chirico G
J Perinatol; 2007 May; 27(5):278-83. PubMed ID: 17363909
[TBL] [Abstract][Full Text] [Related]
39. Serum autoantibodies profile and increased levels of circulating intercellular adhesion molecule-1: a reflection of the immunologically mediated systemic vasculopathy in rheumatic diseases?
Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
Arch Immunol Ther Exp (Warsz); 2001; 49(6):423-30. PubMed ID: 11814236
[TBL] [Abstract][Full Text] [Related]
40. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
